Collaborate Disseminate
New data from an annual drug-use survey supported by the US National Institutes of Health has found recreational use of psychedelics among older adults in the US is at the highest point ever-recorded in the survey’s nearly 40-year history. The data als… Continue reading Annual US drug survey finds use of psychedelics at a record high
A pair of unassuming Australian psychedelic researchers are proposing a radical paradigm shift to the way psychotherapy is conducted. The pair have developed a unique protocol for incorporating virtual reality into the still experimental mode of psyche… Continue reading Meet two researchers bringing VR to psychedelic therapy
A first-of-its-kind trial exploring MDMA-assisted therapy in a group setting is about to commence following the resolution of a clinical hold placed by the US Food and Drug Administration (FDA) that paused progress for several months. The goal of the g… Continue reading First-of-its-kind MDMA group therapy trial set to commence
Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can generate rapid and sustained reductions to anxiety,… Continue reading Promising early results from largest-ever trial testing LSD for anxiety
An ongoing study is testing a new kind of neuroimaging device designed to easily capture brain activity in real-time. These preliminary experiments will investigate the effects of ketamine on functional connectivity in the brain before, during and afte… Continue reading Brain imaging helmet tracks psychedelic experiences in ketamine study
A new study published in the journal Neuropsychopharmacology has reported the results of the first modern clinical investigation to compare the acute effects of psychedelics LSD and psilocybin. The landmark study reveals little subjective difference be… Continue reading Landmark trial compares LSD and psilocybin trips, finds few differences
Just weeks after a double-blind, placebo-controlled trial found psilocybin microdosing to be no different to placebo, another study has been published that found LSD microdoses have no effect on mood or cognition. The new research builds on a small but… Continue reading Another trial finds no evidence LSD microdosing does anything
New research published in the Journal of Psychopharmacology has offered valuable insights into the long-term effects of psilocybin-assisted psychotherapy for depression. The study reports more than half the original cohort were still in remission 12 mo… Continue reading Psychedelic therapy for depression still effective one year later
Over the last couple of years, a novel cannabinoid has quietly grown in popularity. Delta-8 THC is similar to its more commonly known psychoactive cousin, delta-9 THC, but a legal loophole has led to its broad use across the United States despite safet… Continue reading What is delta-8 THC and is it a safe cannabis alternative?
With psychedelics well and truly hitting the mainstream, scientists are finally subjecting many anecdotal claims to the rigors of clinical research. The phenomenon of microdosing is one of those well-known psychedelic practices that many advocates arde… Continue reading No difference between psilocybin microdosing and placebo, trial finds